JMP Securities lifts Axon stock price target to $725

Published 04/02/2025, 11:00
JMP Securities lifts Axon stock price target to $725

On Tuesday, JMP Securities analyst Trevor Walsh increased the price target for Axon Enterprise stock on (NASDAQ:AXON) to $725 from the previous $610. The firm sustained its Market Outperform rating on the stock, signaling confidence in the company’s growth trajectory. Currently trading at $658.11, Axon has demonstrated remarkable momentum with a 156% return over the past year. According to InvestingPro data, analysts maintain a strong buy consensus with price targets ranging from $385 to $800. Walsh highlighted the effectiveness of Axon’s products in enhancing police officer efficiency and the potential for significant time savings, particularly through the company’s software solutions.

Axon Enterprise is expected to further leverage its product narrative in 2025 with the introduction of the AI Era Plan bundle, which represents a $1.8 billion opportunity according to the analyst. This new offering is anticipated to strengthen Axon’s market position and capitalize on emerging trends within the industry.

The analyst also noted the growing demand for counter-unmanned aerial system (C-UAS) and counter-drone solutions, which have applications in public safety, critical infrastructure, and military/defense sectors. This increased focus on aerial security is seen as a response to the evolving needs of these domains.

Moreover, the value of drone-as-a-first responder (DFR) programs was emphasized as a significant asset for public safety organizations. DFR programs are considered a force multiplier, providing a strategic advantage in the context of ongoing recruitment and retention challenges faced by these organizations.

In summary, JMP Securities’ revised price target reflects a bullish outlook on Axon’s prospects, driven by strong sales performance, innovative product offerings, and the company’s strategic positioning to address current and future market needs in the public safety and defense sectors. InvestingPro analysis reveals the company maintains a "GREAT" financial health score, with 20+ additional investment insights available to subscribers through their comprehensive Pro Research Report.

In other recent news, Axon Enterprise has been the subject of significant attention from a number of financial firms. Goldman Sachs analyst Michael Ng has raised the target price for Axon to $700, maintaining a Buy rating on the company. Ng’s analysis suggests that Axon is expected to report a robust $148 million in EBITDA for the fourth quarter of 2024, a figure above the consensus estimate. TD Cowen initiated coverage with a Buy rating, citing Axon’s robust market position and the potential for strong Q4 bookings. Raymond (NSE:RYMD) James analyst Brian Gesuale revised the price target for Axon to $645, seeing the recent 20% stock correction as a buying opportunity. Baird raised its stock price target for Axon to $800, highlighting the company’s growth prospects in artificial intelligence. Lastly, Morgan Stanley (NYSE:MS) upgraded Axon’s stock from Equalweight to Overweight and increased the price target to $700. These recent developments underline the positive outlook for Axon Enterprise.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.